Transdermal administration of azapirones

Details Transdermal administration of azapirones Transdermal administration of azapirones

1995-06-07

1998-10-06

Weddington, Kevin E.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424449, 514252, A61K 970, A61F 1302, A61F 1300, A61L 1516

Patent

active

058173315

ABSTRACT:
In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.

REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3717634 (1973-02-01), Wu et al.
patent: 3731683 (1973-05-01), Zaffaroni
patent: 3742951 (1973-07-01), Zaffaroni
patent: 3797494 (1974-03-01), Zaffaroni
patent: 3976776 (1976-08-01), Wu et al.
patent: 3996934 (1976-12-01), Zaffaroni
patent: 4182763 (1980-01-01), Casten et al.
patent: 4438119 (1984-03-01), Allen et al.
patent: 4634703 (1987-01-01), Kurtz et al.
patent: 4640921 (1987-02-01), Othmer et al.
patent: 4687772 (1987-08-01), Alderdice
patent: 4705796 (1987-11-01), Hendry et al.
patent: 4777173 (1988-10-01), Shrotryia et al.
patent: 4788064 (1988-11-01), Patel et al.
patent: 4788189 (1988-11-01), Glazer
patent: 4839174 (1989-06-01), Baker et al.
patent: 4871738 (1989-10-01), Optiz et al.
patent: 4940585 (1990-07-01), Hapworth
patent: 4943428 (1990-07-01), Lucot et al.
patent: 4954343 (1990-09-01), Hosaka et al.
patent: 4963361 (1990-10-01), Kawazi
patent: 4971799 (1990-11-01), Nakagawa et al.
patent: 4978532 (1990-12-01), El-Rashidy
patent: 5032403 (1991-07-01), Sinnreich
patent: 5185329 (1993-02-01), Gawin et al.
patent: 5633009 (1997-05-01), Kenealy et al.
Gawin, et al., "Buspirone Reduces Smoking," Arch. Gen. Psychiatry, vol. 46, pp. 288-289 (1989).
Gawin, et al., "Potential Use of Buspirone as Treatment for Smoking Cessation: A Preliminary Trial," Family Practice Recertification, vol. 11, No. 9, pp. 74-78 (1989).
Wei, et al., "Effect of Clonidine on Cigarette Cessation and in the Alleviation of Withdrawl Symptoms," British Journal of Addiction, vol. 83, pp. 1221-1226 (1988).
New, "The Discovery and Development of Buspirone: A New Approach to the Treatment of Anxiety," Medicinal Research Reviews, vol. 10, pp. 283-326 (1990).
Cleary, "Transdermal Drug Delivery," Cosmetics and Toiletries, vo. 106, pp. 97-109 (1991).
Eison et al., "Mechanism of Action of Buspirone: Current Perspectives," Burpirone Mechanisms and Clinical Aspects, G. Tunnicliff, A. Eison, D. Taylor, eds., Academic Press, Inc., New York, pp. 279-326 (1991).

Affiliated with

Also associated with

Rating

Transdermal administration of azapirones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal administration of azapirones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal administration of azapirones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-74631